| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |